BMC Clinical Pharmacology BioMed Central Research article Open Access Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women Ekasin Anupongsanugool1, Supanimit Teekachunhatean*1, Noppamas Rojanasthien1, Saipin Pongsatha2 and Chaichan Sangdee1 Address: 1Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Thailand and 2Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Thailand Email: Ekasin Anupongsanugool -
[email protected]; Supanimit Teekachunhatean* -
[email protected]; Noppamas Rojanasthien -
[email protected]; Saipin Pongsatha -
[email protected]; Chaichan Sangdee -
[email protected] * Corresponding author Published: 03 March 2005 Received: 27 August 2004 Accepted: 03 March 2005 BMC Clinical Pharmacology 2005, 5:2 doi:10.1186/1472-6904-5-2 This article is available from: http://www.biomedcentral.com/1472-6904/5/2 © 2005 Anupongsanugool et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Isoflavones from soybeans may provide some beneficial impacts on postmenopausal health. The purpose of this study was to compare the pharmacokinetics and bioavailability of plasma isoflavones (daidzein and genistein) after a single dose of orally administered soy beverage and soy extract capsules in postmenopausal Thai women. Methods: We conducted a randomized two-phase crossover pharmacokinetic study in 12 postmenopausal Thai women. In the first phase, each subject randomly received either 2 soy extract capsules (containing daidzin : genistin = 7.79 : 22.57 mg), or soy beverage prepared from 15 g of soy flour (containing daidzin : genistin = 9.27 : 10.51 mg).